These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1855435)

  • 1. Glucose disposal and intermediary metabolism during one year of continuous subcutaneous insulin infusion (CSII).
    Nijs HG; Radder JK; Poorthuis BJ; Krans HM
    Diabetes Res Clin Pract; 1991 Apr; 12(1):1-9. PubMed ID: 1855435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in type 1 (insulin-dependent) diabetes: dissimilarities for glucose and intermediary metabolites.
    Nijs HG; Radder JK; Poorthuis BJ; Krans HM
    Diabetes Res; 1990 Sep; 15(1):15-9. PubMed ID: 2132195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy.
    Donga E; van Dijk M; Hoogma RP; Corssmit EP; Romijn JA
    Diabetes Metab Res Rev; 2013 Jan; 29(1):33-8. PubMed ID: 22936679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The course and determinants of insulin action in type 1 (insulin-dependent) diabetes mellitus.
    Nijs HG; Radder JK; Frölich M; Krans HM
    Diabetologia; 1989 Jan; 32(1):20-7. PubMed ID: 2651185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII).
    Schmitz O; Sorensen SS; Alberti KG; Orskov H; Hansen HE
    J Diabet Complications; 1987; 1(3):81-6. PubMed ID: 2969910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved insulin sensitivity in patients with type I diabetes mellitus after CSII.
    Simonson DC; Tamborlane WV; Sherwin RS; Smith JD; DeFronzo RA
    Diabetes; 1985 Aug; 34 Suppl 3():80-6. PubMed ID: 3894130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous basal insulin infusion without premeal boluses in insulin-dependent diabetes mellitus therapy.
    Cimino A; Valentini U; Rotondi A; Candrina R; Salvi A; Spandrio S; Radaeli E; Giustina G
    Acta Diabetol Lat; 1987; 24(3):193-8. PubMed ID: 3318256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
    Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
    J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High density lipoprotein subfractions during continuous insulin infusion therapy.
    Helve E
    Atherosclerosis; 1987 Apr; 64(2-3):173-80. PubMed ID: 3300667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic response to fasting exercise in adolescent insulin-dependent diabetic subjects treated with continuous subcutaneous insulin infusion and intensive conventional therapy.
    Schiffrin A; Parikh S; Marliss EB; Desrosiers MM
    Diabetes Care; 1984; 7(3):255-60. PubMed ID: 6376018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
    Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM.
    Caprio S; Tamborlane WV; Zych K; Gerow K; Sherwin RS
    Diabetes; 1993 Apr; 42(4):550-5. PubMed ID: 8454105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.
    Attia N; Jones TW; Holcombe J; Tamborlane WV
    Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy.
    Yki-Järvinen H; Koivisto VA
    J Clin Endocrinol Metab; 1984 Sep; 59(3):371-8. PubMed ID: 6430945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion.
    Olsson PO; Arnqvist H; Von Schenck H; Ottosson AM
    Diabetes Care; 1987; 10(6):702-6. PubMed ID: 3322726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediary metabolism, insulin sensitivity and insulin receptor status under comparable long-term therapy with insulin injections and continuous subcutaneous insulin infusion.
    Marshall SM; Taylor R; Home PD; Alberti KG
    Acta Endocrinol (Copenh); 1988 Apr; 117(4):417-27. PubMed ID: 3291523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
    Luzi L; Petrides AS; De Fronzo RA
    Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes.
    Yki-Järvinen H; Koivisto VA
    J Clin Endocrinol Metab; 1984 Apr; 58(4):659-66. PubMed ID: 6365945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.